Clinical trial
Endothelial Microparticles as a Biomarker for Diagnosis and Prognosis in Early Sepsis
NCT01998139 is registered in ClinicalTrials.gov with Weill Medical College of Cornell University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Endothelial Microparticles as a Biomarker for Diagnosis and Prognosis in Early Sepsis
- Lead sponsor
- Weill Medical College of Cornell University
- Phase
- Observational
- Overall status
- Completed
- Start date
- July 31, 2013
- Completion date
- February 28, 2019
- Enrollment
- 137 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.